Effects of Hydroxyethyl‐Starch‐Bound Deferoxamine on Ischemia/Reperfusion Injury in Chronic Nerve Compression
Effects of Hydroxyethyl‐Starch‐Bound Deferoxamine on Ischemia/Reperfusion Injury in Chronic Nerve Compression
复制标题
羟乙基淀粉结合的去铁胺对慢性神经受压缺血/再灌注损伤的影响
DOI:
10.1055/s-2007-1000211
复制
发表时间:
1998
影响因子:
2.1
通讯作者:
Kyle Bickel
中科院分区:
文献类型:
--
作者:
P. Marin;M. Im;J. Girotto;G. Borschel;Kyle Bickel
The authors have demonstrated previously that pretreatment with deferoxamine, an iron chelator and antioxidant, at the time of release in acute nerve compression, provided protection against ischemia/reperfusion (I/R) injury. In the present study, they evaluated whether therapeutic intervention with hydroxyethyl-starch-bound deferoxamine (HES-DFO) at the time of release of the chronically-compressed peripheral nerve protects the nerve from I/R injury. The sciatic nerves of 43 male Sprague-Dawley rats, weighing 325 to 350 g, were subjected to 8 weeks of compression with Silastic tubing. The treatment group received intravenous HES-DFO (70 mg/kg) at the time of decompression, while the control group received an equal volume of intravenous hetastarch vehicle at the same time schedule and route. Nerve-tissue samples from the compression site, as well as contralateral noncompressed nerves, were assayed for malondialdehyde (MDA), a marker of I/R injury. The control group exhibited MDA levels up to five times normal, and did not return to normal for 21 days. In contrast, the HES-DFO group had MDA levels that were not statistically significantly different from normal levels. The results confirm that pretreatment with HES-DFO prior to the surgical decompression of chronically-compressed nerve provides marked protection against I/R injury.
DOI:
10.1016/0022-4804(89)90221-7
发表时间:
1989
期刊:
The Journal of surgical research
影响因子:
--
作者:
Yoon,JO;Im,MJ;Manson,PN;Bulkley,GB;Hoopes,JE
通讯作者:
Hoopes,JE
影响因子:
19.6
作者:
PALLER, MS;HEDLUND, BE;WATERFIELD, R
通讯作者:
WATERFIELD, R